About MEAJO | Editorial board | Search | Ahead of print | Current Issue | Archives | Instructions to authors | Online submission | Subscribe | Advertise | Contact | Login 
Middle East African Journal of Ophthalmology Middle East African Journal of Ophthalmology
Users Online: 787   Home Print this page Email this page Small font sizeDefault font sizeIncrease font size
SYMPOSIUM - GLAUCOMA
Year : 2009  |  Volume : 16  |  Issue : 3  |  Page : 138-140

Glaukos iStent® trabecular micro-bypass


Laurel Eye Clinic, 50 Waterford Pike, Brookville, PA 15825

Correspondence Address:
Louis D Nichamin
Laurel Eye Clinic, 50 Waterford Pike, Brookville, PA 15825

Login to access the Email id

Source of Support: None, Conflict of Interest: None


DOI: 10.4103/0974-9233.56227

Rights and Permissions

The iStent trabecular micro-bypass system (Glaukos Corp. Laguna Hills, CA) was developed to address the limitations of current medical and surgical therapies for glaucoma treatment. The iStent; is inserted ab interno through a small temporal clear corneal incision, bypassing the trabecular meshwork and placed in Schlemm's canal at the lower nasal quadrant. Implantation of this stent into Schlemm's canal allows aqueous humor to drain directly from the anterior chamber into Schlemm's canal bypassing the obstructed trabecular meshwork. For this review, a Medline search was performed using the terms "trabecular micro-bypass stent" and "trabecular bypass stent." The online abstract database for the American Academy of Ophthalmology was also reviewed. Abstracts which duplicated published articles were excluded. All relevant papers (n is equal to three) and abstracts (n is equal to one) were included in this review. Multiple, prospective multi-country, clinical trials have demonstrated the safety and efficacy of iStent in reducing IOP, when compared to traditional treatment modalities, while reducing/ eliminating the need for ocular antihypertensive drugs when implanted in OAG patients during combined cataract surgery or in patients with glaucoma refractory to traditional treatment modalities.


[FULL TEXT] [PDF]*
Print this article     Email this article
 Next article
 Previous article
 Table of Contents

 Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
 Related articles
 Citation Manager
 Access Statistics
 Reader Comments
 Email Alert *
 Add to My List *
 * Requires registration (Free)
 

 Article Access Statistics
    Viewed4040    
    Printed285    
    Emailed2    
    PDF Downloaded319    
    Comments [Add]    
    Cited by others 7    

Recommend this journal